A B S T R A C T Transport of free fatty acids from the blood into the splanchnic region and their conversion to triglycerides of very low density lipoproteins, together with estimates of splanchnic oxidation of free fatty acids to ketones and to carbon dioxide and water, have been made in the postabsorptive state in seven normolipemic subjects, six with primary endogenous hyperlipemia and one each with primary dysbetalipoproteinemia and mixed hyperlipemia. Net systemic transport of free fatty acids into the blood was the same in normolipemic and hyperlipemic groups, but a greater fraction was taken up in the splanchnic region in the latter. Transport into the blood in very low density lipoproteins of triglyceride fatty acids derived from free fatty acids was proportional and bore the same relationship to splanchnic uptake of free fatty acids in the two groups. In normolipemic subjects, near equilibration of specific activities after 4 hr infusion of palmitate-1-"C showed that almost all triglyceride fatty acids of very low density lipoproteins and acetoacetate were derived from free fatty acids taken up in the splanchnic region. In the hyperlipemic subjects, equilibration of free fatty acidcarbon with acetoacetate was almost complete, but not with triglyceride fatty acids, owing at least in part to increased pool size. Comparison of the rate of equilibraPortions of this work were presented at the Deuel Conference on Lipids, Carmel, Calif., 21 February 1968 (1) tion of triglyceride fatty acids-'4C with rate of inflow transport from the splanchnic region, together with other data, indicated that most of the circulating triglyceride fatty acids of very low density lipoproteins in hyperlipemic subjects were also derived from free fatty acids. Although mean inflow transport of triglyceride fatty acids was greater in the hyperlipemic subjects, it correlated poorly with their concentration and it appeared that efficiency of mechanisms for extrahepatic removal must be a major determinant of the concentration of triglycerides in blood plasma of the normolipemic as well as the hyperlipemic subjects. Estimates of splanchnic respiratory quotient supported the concept that oxidation of free fatty acids accounts for almost all of splanchnic oxygen consumption in the postabsorptive state. Splanchnic oxygen consumption was greater in the hyperlipemics, but fractional oxidation of free fatty acids to ketones was higher in normolipemic subjects. Calculations of splanchnic balance indicate that a larger fraction of free fatty acids was stored in lipids of splanchnic tissues in the hyperlipemics. No differences were found between the two groups in net splanchnic transport of glucose, lactate, or glycerol.
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INTRODUCTION
The liver is a major site of removal of free fatty acids (FFA) from the blood. In the postabsorptive state, FFA are presumed to be the principal substrate for its oxidative metabolism (2) and are virtually the sole precursor of triglyceride fatty acids (TGFA) secreted from the liver into the blood (3) (4) (5) . Alterations in hepatic metabolism of FFA may be related causally to the metabolic derangements of diabetes mellitus, fatty infiltration of the liver, and various hyperlipemias. A variety of approaches have been used to evaluate such (7); phospholipids (8) ; triglycerides (9); protein (10) .
derangements in experimental animals and in man, but there has been no concerted effort to quantify the hepatic uptake and metabolic conversions of FFA directly and under ordinary conditions in vivo. Recent studies in dogs with normal and accelerated rates of fat mobilization (6) have shown that certain aspects of hepatic metabolism of FFA can be quantified during continuous intravenous infusion of tracer FFA by sampling arterial and hepatic venous blood even though most of the blood entering the liver is derived from the portal vein. This conclusion is derived chiefly from two observations: (a) the liver takes up titratable FFA and palmitate-14C in substantial amounts from the blood but is not itself a source of circulating FFA; and (b) two of the major metabolic products of FFA which enter hepatic venous blood from the splanchnic region-triglycerides and ketone bodies-are svnthesized solely in the liver. These studies also showed that liver accounts for about 75% of the FFA removed from the blood in the splanchnic region.
On the basis of this information, we have undertaken studies of the splanchnic uptake of FFA and of the conversion of the FFA to major metabolic products in man.
Here we report results of our initial studies in healthy subjects and subjects with primary endogenous hyperlipemias. The data obtained provide quantitative information concerning the contribution of FFA to hepatic oxidative metabolism in humans fasted overnight and the first direct and unambiguous measurements of conversion of FFA taken up in the splanchnic region to plasma TGFA which are shown to be secreted almost entirely in very low density lipoproteins (VLDL). They also indicate that conversion of FFA to TGFA in liver is not altered in states of primary endogenous hyperlipemia and suggest that impaired extrahepatic metabolism of VLDL triglycerides has a dominant role in the pathogenesis of these common metabolic disorders.
METHODS
Experimental subjects (Table I ). The seven normolipemic subjects included four healthy, nonobese men, 20-30 yr old, a 47 yr old man with chronic asthmatic bronchitis, and a 38 yr old man and a 59 yr old woman who were moderately obese. These subjects had no clinical evidence of metabolic disease and had normal serum concentrations of creatinine, uric acid, and protein-bound iodine. Tests of hepatic function (serum albumin, globulin, alkaline phosphatase, glutamic-oxaloacetic transaminase, and bilirubin) were normal. Serum concentrations of lipids and composition of VLDL were also in the generally accepted range of normal. The eight hyperlipemic subjects included four men and four women. Six had VLDL of normal composition and electrophoretic mobility (primary endogenous hyperlipemia). One man (M. G.) had VLDL which were abnormally rich in cholesterol and poor in triglycerides and a broad-beta band upon lipoprotein electrophoresis in agarose gel (primary dysbetalipoproteinemia 174  141  65  -260  192  110  234  182  65  17  7  20  50  7  206  166  68  17  7  23  46  7  176  182  61  17  6  14  57  7  213  192  115  15  6  16  57  7  277  257  67  -249  235  366  14  8  16  55  7  411  561  560  15  9  18   50  9  357  367  484  20  7  21  44  8  223  301  206  15  6  16  57  7  441  276  333  28   10   17  37   8  204  190  194  11  6  19  57  7  380  390  842  17  7  15  54  7  154  215  550  10  7  18  58   6 sometimes had chylomicronemia (primary mixed hyperlipemia) but it was not present at the time of study. A. Fr. had had gout for 15 yr, treated with probenecid, and serum uric acid was increased in C. S. and A. S.; serum creatinine, protein-bound iodine, resting electrocardiogram, and X-ray of the chest were normal in all. Tests of hepatic function were normal in all except for slight increases of alkaline phosphatase in M. G., A. S., and A. Fr. Fasting blood glucose concentration was normal in all but A. Fr., who had mild fasting hyperglycemia on the day of study. Intravenous glucose tolerance (0.5 g/kg) was reduced (k values below 1.00) in A. F., E. J., A. Fr., and control subject D. C. It was not tested in the thin normolipemic subjects or in hyperlipemic subject D. A. Oral glucose tolerance was normal in D. A. All hyperlipemic subjects except G. S. had been followed for 1 yr or more. Most were on "diabetic" diets with restriction of simple sugars, but none had lost appreciable weight or was taking drugs known to affect plasma lipids in the 2 months before study. None had unusually large intake of alcoholic beverages. All subjects were admitted to the hospital at least 3 days before splanchnic metabolism was studied and maintained on diets calculated to maintain weight and containing the following distribution of calories: 16% protein, 40%o carbohydrate, and 44% fat. The dinner on the night preceding the study contained less than 5 g of fat with carbohydrate added to maintain constant caloric intake. Experimental procedure. The subjects were brought to the laboratory without premedication 14 hr after the last meal and rested on a fluoroscopy No heparin was used. Every effort was made to maintain a quiet and relaxed atmosphere and most subjects listened to music during the procedure. During the 4 hr of study, discomfort was minimized by occasional infiltration of lidocaine into the site of the incision and the subjects were allowed to bend their knees except for a period of 5 min before each blood sampling. The blood samples were taken from the arterial and hepatic venous catheters at 20-to 30-min intervals in the following order: 7 ml into heparinized, oiled syringes for analysis of blood gases and volume of packed red blood cells; 18 ml into dry, glass syringes which was transferred to test tubes containing 0.01 ml of heparin (10 U) per ml blood and chilled in ice; duplicate samples of 2i ml into 3-ml plastic syringes for estimation of 14CO2 and 6 ml for measurement of indocyanine green which was placed into a plain test tube and allowed to clot. Blood was replaced with 0.15 M sodium chloride solution.
Analytical methods. Triplicate 0.050 ml samples were taken from the heparinized blood for analysis of glucose (11) and 3 ml was deproteinized in 3 ml of 30% perchloric acid for estimation of glycerol (12) , acetoacetate and ,B-hydroxybutyrate (6) , and lactate (13) In dogs receiving a constant intravenous infusion of palmitate-1-'C, the steady-state specific activity of FFA in portal venous blood was about 10% lower than that in arterial blood, while the composition of FFA was identical in the two sites. This indicates that in the extrahepatic splanchnic region, FFA are not only taken up into tissues but also released into the blood (presumably from mesenteric and omental adipose tissue). In contrast, the specific activity of FFA in hepatic venous blood was not distinguishable from that entering the liver, indicating that FFA are not released from the liver. Under the assumption that FFA released in the extrahepatic splanchnic region contain no "C, net release of FFA from the region drained by the portal vein and from the liver can readily be calculated (6) . The difference between these two values represents the quantity of FFA released from the extrahepatic region which is taken up in the liver and thus does not reach the systemic circulation. In the present studies, only arterial and hepatic venous blood was sampled so that values for uptake of FFA based upon extraction fraction of palmitate-"C in the splanchnic region underestimate total splanchnic uptake. However, from the reduction in specific activity of FFA between artery and hepatic vein, net splanchnic release of FFA can be calculated. (a) Net splanchnic release of FFA (/moles per ml plasma) = arterial concentration X extraction fraction of palmitate-C -(arterial concentration -hepatic venous concentration). In the studies in dogs, the hepatic extraction fraction for FFA averaged about 80% (range 73-84%) of that for the entire splanchnic region. If it is assumed that this value also applies to man, the total splanchnic release of FFA can be calculated and, by difference, hepatic uptake of FFA released from the extrahepatic splanchnic region can be estimated. RESULTS Values for volume of packed red blood cells and for concentration of total protein of plasma in arterial and hepatic venous samples differed by no more than 2%. The normolipemic and hyperlipemic subjects had generally similar levels of FFA, glycerol, and P-hydroxybutyrate (Table II) . However, the concentration of acetoacetate was lower in the hyperlipemic group. The concentrations of FFA and glycerol remained stable during the 4 hr period of study, but ketone levels rose gradually (Fig. 1) . Concentrations of glucose and lactate were similar in the two groups, except for mild fasting hyperglycemia in A.Fr. The concentration of VLDL-TGFA varied considerably in both groups of subjects and was on the average 8 times higher in the hyperlipemic subjects. Comparison of TGFA concentrations in plasma and VLDL shows that almost the entire increase in TGFA of hyperlipemics was in VLDL.
Blood flow to the splanchnic region was in the expected range and was similar in the two groups, but splanchnic oxygen consumption was higher (by 27%) in-the hyperlipemic subjects. Splanchnic R.Q. was measured in only three of the normolipemic subjects, but was in the same range as that observed in the hyperlipemics. The relationship of over-all splanchnic oxidative metabolism to that of FFA will be considered later.
Net transport of FFA into arterial blood plasma was generally in the high normal range and was similar in the two groups (Table III) . The turnover rate of FFA was in the range expected for rested, postabsorptive subjects (15) . A significantly larger amount of FFA (Fig. 3) . In all subjects, labeled TGFA appeared in hepatic venous blood plasma 30-40 min after infusion of palmitate-w"C was begun. The rate of appearance increased rapidly at first, but no further increase in rate could be detected after 120 min in either the normolipemic or hyperlipemic groups (Fig. 4) . The mean value between 120 and 240 min was therefore used to provide an estimate of the conversion of FFA to TGFA entering the blood from the splanchnic region. These estimates amount to about 17% in both groups of subjects (Table IV) . This metabolic pathway thus accounted for 7-8% of FFA transported in normolipemic subjects and about 10% in hyperlipemics. Although there was appreciable individual variation, mean values for conversion of FFA to TGFA in whole plasma and in VLDL were closely similar in both groups; thus, no evidence for transport of TGFA derived from FFA into plasma low density or high density lipoproteins was obtained. In the four normolipemic subjects whose VLDL-TGFA levels were lowest, their specific activity reached a value within 10% of that of FFA in hepatic venous blood plasma (assumed to be equal to that of FFA entering the liver) after 240 min infusion of palmitate-UC (Table IV and (Fig. 5) . Net inflow transport of TGFA derived from FFA taken up in splanchnic tissues can be estimated directly from the values for splanchnic uptake of FFA and their fractional conversion to TGFA in plasma or VLDL (Table IV) . The two estimates did not differ systematically and were closely correlated (r = 0.82, P < 0.001). For technical reasons, the values derived from measurements of TGFA-14C in whole plasma are considered to provide the best estimates of net inflow transport. These values provide a valid estimate of net inflow transport of TGFA provided there are no other precursors of plasma TGFA under the conditions of study.
From the values for specific activity of FFA and VLDL-TGFA, this appears to be the case in the four subjects with low concentrations of VLDL-TGFA. Additionally, inflow transport estimated from arteriovenous differences in concentration VLDL-TGFA in six of the normolipemic subjects did not differ systematically from those based on splanchnic production of labeled TGFA (Fig. 7) . Generally, for a given rate of production, hyperlipemic subjects had much higher plasma levels of VLDL-TGFA. The turnover time (reciprocal of turnover rate) of VLDL-TGFA correlated closely with their content in plasma in both normolipemic (y =-68 + 0.085 x, r = 0.98, P < 0.001) and hyperlipemic (y = -48 + 0.036 x, r = 0.93, P < 0.001) subjects as well as in the combined groups (y = 26 + 0.033x, r = 0.95, P < 0.001). Splanchnic oxidative metabolism of FFA did differ in the two groups of subjects. Conversion to ketones accounted for 31% of palmitate-l4C taken up in the splanchnic region in normal subjects compared with a value of 20% in the hyperlipemics (Table IV) . These values underestimate the actual conversions to the extent that ketones are extracted from the blood in the extrahepatic splanchnic area. Results obtained in dogs (6) suggest that the underestimate is of the order of 20%. Taken together with the probability that about 20% of splanchnic uptake of FFA is extrahepatic, this suggests that almost half of the FFA entering the livers of our normolipemic subjects and about one-third in the hyperlipemics was oxidized to ketones. During the period of study, production of acetoacetate and P-hydroxybutyrate tended to rise in the hyperlipemic groups but not in the Splanchnic Metabolism of Plasma Free Fatty Acids and Triglycerides T controls (Fig. 1) . Arterial levels of ketones, however, increased with time in both groups and this did not appear to be related to increased splanchnic production, particularly in the normolipemic group. Significant correlations were observed (Fig. 8) between the concentrations of acetoacetate and P-hydroxybutyrate and their production rates as well as between the ratio of P-hydroxybutyrate to acetoacetate in arterial blood and the ratio of production rates of this redox pair. These correlations did not differ significantly between the two groups of subjects. However, the concentration of ketones was directly related to ponderal index (r = 0.66, P < 0.01). This was not true for production rates. Conversion of palmitate-*C to CO* appearing in hepatic venous blood was, respectively, 8 and 13% (Table IV) Min of infusion of palmitate1-J4C. DISCUSSION These studies indicate that the splanchnic region accounts for a larger fraction of FFA removed from the blood in man than suggested from earlier work (23, 24) . With the constant infusion technique, it has been possible to correct net uptake of FFA for FFA entering hepatic venous blcood from the splanchnic region and also to estimate the quantity of these FFA which are taken up in the liver. We are unable to determine the magnitude of the error introduced in calculation of this portion of splanchnic uptake; however, since it usually accounts for a small part of the total, its influence on calculated fluxes of FFA through various pathways must be small.
Splanchnic release of FFA apparently can vary, over a wide range, not closely related in different subjects to over-all rate of fat mobilization from adipose tissue. Variability of the fraction of transported FFA taken up from the blood in the splanchnic region was also shown; in our hyperlipemic subjects this fraction was greater than one-half. These factors together with net inflow transport, are the main determinants of splanchnic uptake.
The large uptake of FFA in the splanchnic region has suggested that, as in muscle, they may be the prime substrate of oxidative metabolism (2) . It has long been known that the R.Q. is low in perfused liver (25) been available. It was not possible to make a direct and intake of protein. The mean value of 0.65 for corrected unambiguous measurement even with the present ap-R.Q. provides strong evidence that fatty acids are the proach because of the complicated fate of acyl CoA-most important source of CO* produced in the tricarbon in a gluconeogenic tissue such as the liver. Iso-carboxylic acid cycle. The value may be expected to err topic equilibration of this carbon with other precursors slightly on the low side because of neglect of extramitoof oxaloacetate (chiefly amino acids) results in the ap-chondrial oxygen-utilizing reactions such as those conpearance of the SC in other compounds, mainly glucose. cerned with hydroxylations. The calculations shown in We have been able to account for up to 2% of palmitate- Table VI suggest that normally about two-thirds of the 'C in extracellular glucose after 2 hr of constant infu-FFA taken up in the splanchnic region are oxidized with sion into normolipemic subjects.' This would amount approximately equal fractions converted to ketone bodies to about 5% of that taken up in the splanchnic region. and to CG0 and water. Of the remaining one-third, about
Without quantitative values for this and similar pro-half is secreted as VLDL-TGFA while the remainder cesses, it is clear that conversion to CO of 'C in palmi-presumably is stored in hepatic lipids. In hyperlipemic tate or any other compound entering the tricarboxylic subjects, a smaller fraction of FFA was oxidized to acid cycle in the liver cannot provide reliable informa-ketones. This difference could not be related to their intion concerning the extent of oxidation. It is for this rea-creased fat stores, since neither fractional conversion son that we made the estimates shown in Table VI . of FFA to ketones nor splanchnic production of ketones The corrected value for splanchnic R.Q. depends upon correlated with ponderal index. The greater splanchnic unambiguous calculation of oxygen utilized during con-consumption of oxygen in hyperlipemic subjects did not version of fatty acids to ketone bodies and an assumed suffice to balance the increased uptake of FFA. About value for fixation of COs in urea. The latter value is not two-thirds of the FFA which escaped oxidation in these expected to be much in error for subjects with known subject were apparently stored and one-third secreted in VLDL-TGFA. The extent of storage did not appear 'Wolfe, B. M., and R. J. Havel. Unpublished data.
-to correlate with body ifat -content as estimated from ponderal index and the reasons for this difference between control and hyperlipemic subjects are obscure. We also have no explanation for the greater fractional extraction of FFA in the splanchnic region in the latter group, which was the major factor underlying their greater splanchnic uptake of FFA. Possibly other metabolic abnormalities known to exist in subjects with endogenous and mixed hyperlipemia, such as insulin resistance and hyperinsulinism, are involved. The larger release of FFA from the extrahepatic splanchnic (26) . A second potential source of VLDL-TGFA in our hyperlipemic subjects is preformed fatty acids stored in hepatic lipids. This situation may obtain in insulindeficient, ketotic diabetic dogs with grossly fatty livers. In such animals, it has been found that only slightly more than half of the ketones produced by the liver are derived from FFA taken up from the blood (6), so that the fatty acyl CoA pool leading to ketogenesis may be derived in part from other sources. This pool could also contribute to synthesis of TGFA in the extramitochondrial compartment of the cell. In our hyperlipemic subjects, this was not the case (Table V) , although they did appear to store more FFA in hepatic lipids than the normolipemics (Table VI) . Current information concerning formation of VLDL-TGFA suggests that they arise in the smooth endoplasmic reticulum, the extramitochondrial site of esterification of fatty acids, and that they remain enclosed within a tubular system until they are secreted from the parenchymal cell (27) . Therefore, in the absence of evidence for separate pools leading to esterification and oxidation of fatty acids, it seems (Table IV) for inflow transport of TGFA calculated from isotopic equilibration (which are predicated upon the assumption that FFA are the absolute precursor) should have been substantially lower than those calculated from fractional conversion of FFA to TGFA. The values, in fact, agreed closely in five hyperlipemic subjects, and the values from isotopic equilibration were higher in two of the three others. Some VLDL, synthesized in intestinal mucosa, enter the blood via the thoracic duct in the postabsorptive state (28) . Since these are thought to be derived primarily from biliary phospholipids (29) , their TGFA might contain appreciable 14C. The agreement between values for inflow transport of TGFA derived from isotopic equilibration and those based upon fractional conversion of FFA to TGFA in the splanchnic region also provides evidence that this source of VLDL is a minor one in postabsorptive humans.
A major conclusion that emerges from our estimates of triglyceride transport from the liver is that a defect in extrahepatic mechanisms for removal of TGFA exists in at least four of our six subjects with endogenous hyperlipemia. A greater inflow transport of TGFA may have contributed to the magnitude of the abnormality in A.F. and G.S. (Table IV and Fig. 7) . Triglyceride concentration was also related closely to efficiency of removal in the normolipemic group, as reflected, in the close correlation between plasma content and turnover time. The normolipemic subjects were on the whole younger and thinner than the hyperlipemics.
However, neither age nor adiposity appears to be related to inflow transport or plasma level of triglycerides in the normolipemic group. A defect in removal also appears to be present in our single subjects with familial dysbetalipoproteinemia and mixed hyperlipemia. Defects in removal might be expected in these latter two subjectsin dysbetalipoproteinemia because of abnormal lipoprotein carrier (30) and in mixed hyperlipemia because removal of exogenous triglycerides also seems to be impaired (31) . The conclusion that a defect in removal is present in the more common endogenous hyperlipemia is more surprising, since no such defect for exogenous TGFA or in the lipoprotein lipase system has been demonstrated (27) . A similar conclusion has been reported recently by Quarfordt, Frank, Shames, Berman, and Steinberg from estimates of transport of VLDL-TGFA derived from multicompartmental analysis of "C in FFA and VLDL-TGFA after pulse-injection of palmitate&UC into normolipemic subjects and subjects with endogenous hyperlipemia (32) . Other studies, however, have led to the opposite conclusion. Reaven, Hill, Gross, and Farquhar have estimated the turnover rate of VLDL-TGFA from the slope of the die-away curve in triglycerides after injecting labeled glycerol (33) (1, 34) . These comparisons show that the two methods seem to give similar results at high triglyceride levels but that our approach provides considerably higher values at normal levels. This comparison and other data have led us to conclude that the method used by these workers underestimates transport of VLDL-TGFA in the normal range. Thus, we have found that rates of inflow transport of TGFA may be closely similar in normolipemic and hyperlipemic subjects whose concentrations of VLDL-TGFA differ by as much as fortyfold (Fig. 7) . Another method which has been employed extensively to measure transport of plasma TGFA in man was proposed by Ryan and Schwartz (35) . Our results permit direct comparison with this method, which depends upon the accumulation of isotope in-plasma TGFA during constant infusion of labeled precursor. This comparison has shown that the method proposed by Ryan and 50% (1, 34) . This results from: (a) neglect of removal of labeled TGFA from the plasma during the period of measurement; and (b) assumption that peripheral venous or arterial FFA are in equilibrium with the precursor pool of VLDL-TGFA in liver. It should be emphasized that the estimates of transport that we have made here apply only to the postabsorptive state in subjects on ordinary diets. Whether transport responds differently in certain hyperlipemic subjects to various maneuvers, such as a low fat, high carbohydrate diet, is not certain (32) . It is, however, pertinent to point out here that a decrease in efficiency of removal would result in greater "sensitivity" to stimuli increasing inflow transport from liver, when absolute changes in concentration are the index.
Another important conclusion that can be made from our measurements of transport of TGFA is that rate of hepatic secretion of VLDL is a direct and apparently linear function of splanchnic uptake of FFA. This supports earlier qualitative studies as well as similar quantitative studies in the dog (6) . Although over-all inflow transport of FFA was not increased in our hyperlipemic subjects, transport of TGFA into the blood was increased in proportion to increased splanchnic uptake of FFA. Different responses to various stimuli affecting transport of FFA, such as insulin and fat-mobilizing hormones, could also intensify the hyperlipemia. These may be of major importance in therapeutic maneuvers even though they may not necessarily be directed against the primary (presumably genetic) defect. Altered hepatic metabolism of FFA can also affect inflow transport of TGFA as demonstrated with the present method in von Gierke's disease (37) and with administration of ethanol (38) .
This study has also provided some new information concerning the dynamics of ketone metabolism in man. As expected, the concentration of ketones in blood was shown to be related directly to net splanchnic production. However, increasing ketone levels during the study were not related to increased rates of production in our control subjects. This indicates that removal of ketones may become less efficient with more prolonged fasting, in agreement with recent studies in dogs (6, 39) . The direct relationship between ketone concentration (but not production) and ponderal index suggests that decreased ketogenesis may not entirely explain the decreased tendency to ketosis observed in obesity (40) . Our data are insufficient to establish that a sex difference exists in ketogenesis. The redox couple, f-hydroxybutyrate-acetoacetate, has been thought to provide a mechanism for equilibrating redox state of pyridine nucleotides in hepatic and extrahepatic tissues. Our observations, which suggest that the blood reflects the situation within the liver and other studies (41) showing that fractional uptake of these two metabolites differs in peripheral tissues, are in keeping with this concept.
Our observations on net splanchnic uptake of lactate and glycerol and production of glucose are in agreement with published data (23, 42, 43) . Other studies have shown that, in subjects fasted overnight, only about half of the glucose secreted can be derived from gluconeogenic precursors.' In spite of this, we found that glucose production correlated with estimated splanchnic oxidation of FFA. Although the extent to which glycogenolysis contributes to blood glucose in each subject is not known, this is the first direct observation, under physiologic conditions, to support the relationship (44) between gluconeogenesis and ketogenesis which has been observed in several model systems.
